Interwest Venture Management Co. bought a new stake in Glaukos Corporation (NYSE:GKOS) during the fourth quarter, Holdings Channel reports. The firm bought 1,018,362 shares of the company’s stock, valued at approximately $34,930,000. Glaukos Corporation accounts for about 8.3% of Interwest Venture Management Co.’s investment portfolio, making the stock its 2nd largest position. Interwest Venture Management Co. owned approximately 3.04% of Glaukos Corporation as of its most recent filing with the SEC.
Several other large investors have also modified their holdings of the company. State Street Corp raised its position in Glaukos Corporation by 6.9% in the fourth quarter. State Street Corp now owns 281,407 shares of the company’s stock valued at $9,653,000 after buying an additional 18,183 shares during the period. Artisan Partners Limited Partnership raised its position in Glaukos Corporation by 196.5% in the fourth quarter. Artisan Partners Limited Partnership now owns 369,893 shares of the company’s stock valued at $12,687,000 after buying an additional 245,157 shares during the period. State Board of Administration of Florida Retirement System raised its position in Glaukos Corporation by 1.9% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 7,699 shares of the company’s stock valued at $264,000 after buying an additional 140 shares during the period. Cavalier Investments LLC purchased a new position in Glaukos Corporation during the fourth quarter valued at approximately $497,000. Finally, Russell Investments Group Ltd. purchased a new position in Glaukos Corporation during the fourth quarter valued at approximately $5,371,000. 77.95% of the stock is currently owned by institutional investors and hedge funds.
Glaukos Corporation (NYSE:GKOS) traded up 0.18% during mid-day trading on Monday, hitting $44.67. The company had a trading volume of 255,257 shares. Glaukos Corporation has a 52-week low of $14.96 and a 52-week high of $45.72. The stock’s 50 day moving average price is $38.91 and its 200 day moving average price is $35.16. The firm has a market cap of $1.50 billion, a P/E ratio of 783.68 and a beta of 1.37.
This report was published by sleekmoney and is the property of of sleekmoney. If you are accessing this report on another site, it was stolen and reposted in violation of United States and international copyright legislation. The legal version of this report can be accessed at http://sleekmoney.com/interwest-venture-management-co-buys-shares-of-1018362-glaukos-corporation-gkos/1658919.html.
Several research analysts have commented on GKOS shares. Cantor Fitzgerald lifted their price target on Glaukos Corporation to $45.00 in a research report on Friday, November 11th. Zacks Investment Research raised Glaukos Corporation from a “hold” rating to a “buy” rating and set a $43.00 price target on the stock in a research report on Tuesday, January 10th. Wells Fargo & Company began coverage on Glaukos Corporation in a research note on Thursday, October 27th. They issued an “outperform” rating on the stock. Finally, Stifel Nicolaus upgraded Glaukos Corporation from a “hold” rating to a “buy” rating and lifted their target price for the company from $42.00 to $45.00 in a research note on Friday, January 6th. Seven equities research analysts have rated the stock with a buy rating, The company currently has a consensus rating of “Buy” and an average price target of $40.67.
In other news, CEO Thomas William Burns sold 200,120 shares of the firm’s stock in a transaction on Tuesday, November 15th. The stock was sold at an average price of $33.68, for a total value of $6,740,041.60. Following the completion of the sale, the chief executive officer now owns 1,388 shares of the company’s stock, valued at $46,747.84. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director William J. Phd Link sold 30,000 shares of the firm’s stock in a transaction on Thursday, November 17th. The stock was sold at an average price of $33.78, for a total value of $1,013,400.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 399,524 shares of company stock valued at $14,431,981. 36.80% of the stock is currently owned by insiders.
About Glaukos Corporation
Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring approximately one millimeter long and approximately 0.33 millimeter wide.
Want to see what other hedge funds are holding GKOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Glaukos Corporation (NYSE:GKOS).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/interwest-venture-management-co-buys-shares-of-1018362-glaukos-corporation-gkos/1658919.html
Receive News & Ratings for Glaukos Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glaukos Corporation and related companies with MarketBeat.com's FREE daily email newsletter.